Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes.
Bradley SarakSubodh VermaC David MazerHwee TeohAdrian QuanRichard E GilbertShaun G GoodmanKaran BamiOtávio R Coelho-FilhoVineeta AhoojaDjeven P DevaVinay GargSumeet GandhiKim A ConnellyAndrew T YanPublished in: Cardiovascular diabetology (2021)
URL: https://www.clinicaltrials.gov/ct2/show/NCT02998970?cond=NCT02998970&draw=2&rank=1 . Unique identifier: NCT02998970.